{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"MSP3: Maria Alice Willrich, Ph.D. ","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/2c46afad\"></iframe>","width":"100%","height":180,"duration":810,"description":"Maria Alice Willrich, Ph.D., discusses kappa free light chain testing, Mayo Clinic Laboratories’ innovative new approach to evaluating for multiple sclerosis. The automated assay detects and measures immunoglobulin kappa free light chains in cerebrospinal fluid. Faster, less expensive, and more sensitive than traditional oligoclonal banding analysis, kappa free light chain testing is a significant quality improvement over manual testing that yields objective, qualitative test results.","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}